Table of Content

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 MARKETS COVERED & REGIONAL SCOPE 24
1.3.2 INCLUSIONS & EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 26
1.5 UNIT CONSIDERED 26
1.6 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 29
2.1.2 PRIMARY DATA 30
2.1.2.1 Key data from primary sources 31
2.1.2.2 Key industry insights 32
2.2 MARKET SIZE ESTIMATION 34
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 39
2.4 MARKET SHARE ESTIMATION 41
2.5 STUDY ASSUMPTIONS 41
2.6 RESEARCH LIMITATIONS 41
2.6.1 SCOPE-RELATED LIMITATIONS 41
2.6.2 METHODOLOGY-RELATED LIMITATIONS 41
2.7 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 DENTAL ANESTHETICS MARKET OVERVIEW 46
4.2 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024) 47
4.3 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
4.4 DENTAL ANESTHETICS MARKET: REGIONAL MIX 48
4.5 DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 49
?
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 51
5.2.1 DRIVERS 51
5.2.1.1 Increasing patient pool for dental treatments 51
5.2.1.1.1 Dental caries and other dental disorders 51
5.2.1.1.2 Geriatric population and edentulism 52
5.2.1.1.3 Periodontal diseases 53
5.2.1.1.4 Changing lifestyles and unhealthy food habits 54
5.2.1.2 Increasing demand for advanced cosmetic dental procedures 54
5.2.1.3 Technological advancements in anesthetic delivery 55
5.2.2 RESTRAINTS 55
5.2.2.1 Potential adverse effects 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Rising number of DSOs and growing private equity investments 56
5.2.3.2 Emerging markets 58
5.2.3.3 Growing dental tourism 58
5.2.4 CHALLENGES 59
5.2.4.1 Dearth of trained dental practitioners 59
5.2.4.2 Needle phobia 59
5.3 PORTER’S FIVE FORCES ANALYSIS 60
5.3.1 INTENSITY OF COMPETITIVE RIVALRY 61
5.3.2 BARGAINING POWER OF SUPPLIERS 61
5.3.3 BARGAINING POWER OF BUYERS 61
5.3.4 THREAT OF SUBSTITUTES 61
5.3.5 THREAT OF NEW ENTRANTS 62
5.4 REGULATORY ANALYSIS 62
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.4.2 REGULATORY LANDSCAPE 65
5.5 INDUSTRY TRENDS 66
5.5.1 METERED SPRAY SYSTEMS 66
5.5.2 JET INJECTION SYSTEMS 66
5.6 REIMBURSEMENT SCENARIO 66
5.7 TECHNOLOGY ANALYSIS 67
5.7.1 KEY TECHNOLOGIES 67
5.7.1.1 Vasoconstrictors 67
5.7.1.2 Buffering agents 67
5.7.2 COMPLEMENTARY TECHNOLOGIES 68
5.7.2.1 Computer-controlled local anesthetic delivery (CCLAD) systems 68
5.7.3 ADJACENT TECHNOLOGIES 68
5.7.3.1 Reversal agents 68
5.8 KEY CONFERENCES & EVENTS, 2025–2026 69
5.9 PRICING ANALYSIS 70
5.9.1 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION 70
5.9.2 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER 70
5.10 TRADE ANALYSIS 71
5.10.1 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024 72
5.10.2 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024 72
5.11 PATENT ANALYSIS 73
5.11.1 PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS 73
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET 73
5.12 VALUE CHAIN ANALYSIS 76
5.13 ECOSYSTEM ANALYSIS 77
5.14 SUPPLY CHAIN ANALYSIS 78
5.15 CASE STUDY ANALYSIS 80
5.15.1 CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY 80
5.15.2 CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA 80
5.15.3 CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES 81
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.17 KEY STAKEHOLDERS & BUYING CRITERIA 82
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
5.17.2 BUYING CRITERIA 83
5.18 ADJACENT MARKET ANALYSIS 84
5.19 UNMET NEEDS/END-USER EXPECTATIONS 84
5.20 IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET 86
5.21 IMPACT OF 2025 US TARIFF – OVERVIEW 86
5.21.1 INTRODUCTION 86
5.21.2 KEY TARIFF RATES 87
5.21.3 PRICE IMPACT ANALYSIS 88
5.21.4 IMPACT ON END-USER INDUSTRIES 88
6 DENTAL ANESTHETICS MARKET, BY DRUG TYPE 89
6.1 INTRODUCTION 90
6.2 LIDOCAINE 92
6.2.1 RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET 92
6.3 MEPIVACAINE 94
6.3.1 UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET 94
6.4 ARTICAINE 96
6.4.1 IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET 96
6.5 BUPIVACAINE 98
6.5.1 PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH 98
6.6 PRILOCAINE 100
6.6.1 LOWER TOXICITY PROFILE TO FUEL UPTAKE 100
6.7 OTHER DRUG TYPES 101
7 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 103
7.1 INTRODUCTION 104
7.2 TOPICAL ANESTHETICS 106
7.2.1 GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND 106
7.3 INJECTABLE ANESTHETICS 108
7.3.1 HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET 108
7.4 SYRINGES 110
7.4.1 ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET 110
7.5 NEEDLES 112
7.5.1 RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH 112
8 DENTAL ANESTHETICS MARKET, BY END USER 114
8.1 INTRODUCTION 115
8.2 HOSPITALS 115
8.2.1 ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET 115
8.3 DENTAL CLINICS 117
8.3.1 RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET 117
8.4 OTHER END USERS 119
9 DENTAL ANESTHETICS MARKET, BY REGION 121
9.1 INTRODUCTION 122
9.2 EUROPE 124
9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 124
9.2.2 GERMANY 127
9.2.2.1 Favorable government policies for reimbursement to expedite growth 127
9.2.3 ITALY 130
9.2.3.1 Rising adoption of digital dentistry techniques to augment growth 130
9.2.4 SPAIN 132
9.2.4.1 Presence of well-established dental healthcare infrastructure to foster growth 132
9.2.5 FRANCE 134
9.2.5.1 Favorable distribution network and reimbursement scenario to aid growth 134
9.2.6 UK 136
9.2.6.1 Booming geriatric population to stimulate growth 136
9.2.7 REST OF EUROPE 138
9.3 NORTH AMERICA 139
9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 140
9.3.2 US 143
9.3.2.1 High per capita income and quality of treatment to support growth 143
9.3.3 CANADA 144
9.3.3.1 Rising healthcare expenditure to sustain growth 144
9.4 ASIA PACIFIC 146
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 147
9.4.2 SOUTH KOREA 150
9.4.2.1 Growing elderly population to fuel market 150
9.4.3 JAPAN 153
9.4.3.1 Surge in age-related dental issues to promote growth 153
9.4.4 CHINA 155
9.4.4.1 Shift in demographic trend to accelerate growth 155
9.4.5 INDIA 157
9.4.5.1 Growing cosmetic dentistry sector to fuel market 157
9.4.6 AUSTRALIA 159
9.4.6.1 Increasing access to dental services to favor growth 159
9.4.7 REST OF ASIA PACIFIC 160
9.5 LATIN AMERICA 162
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 162
9.5.2 BRAZIL 164
9.5.2.1 Booming dental tourism to contribute to growth 164
9.5.3 ARGENTINA 166
9.5.3.1 Growing focus on oral health to propel market 166
9.5.4 MEXICO 168
9.5.4.1 Affordable dental care costs to amplify growth 168
9.5.5 REST OF LATIN AMERICA 170
9.6 MIDDLE EAST & AFRICA 171
9.6.1 GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET 171
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 171
9.7 GCC COUNTRIES 173
9.7.1 INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET 173
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 173
?
10 COMPETITIVE LANDSCAPE 176
10.1 INTRODUCTION 176
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 176
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET 177
10.3 MARKET SHARE ANALYSIS 178
10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 180
10.4.1 STARS 180
10.4.2 EMERGING LEADERS 180
10.4.3 PERVASIVE PLAYERS 181
10.4.4 PARTICIPANTS 181
10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 182
10.4.5.1 Company footprint 182
10.4.5.2 Region footprint 183
10.4.5.3 Drug type footprint 184
10.4.5.4 Route of administration footprint 185
10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 186
10.5.1 PROGRESSIVE COMPANIES 186
10.5.2 RESPONSIVE COMPANIES 186
10.5.3 DYNAMIC COMPANIES 186
10.5.4 STARTING BLOCKS 186
10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 188
10.5.5.1 Detailed list of key startups/SMEs 188
10.5.5.2 Competitive benchmarking of key startups/SMEs 188
10.6 COMPANY VALUATION & FINANCIAL METRICS 189
10.6.1 FINANCIAL METRICS 189
10.6.2 COMPANY VALUATION 189
10.7 BRAND/PRODUCT COMPARISON 190
10.8 COMPETITIVE SCENARIO 191
10.8.1 PRODUCT LAUNCHES 191
10.8.2 DEALS 191
10.8.3 EXPANSIONS 192
10.8.4 OTHER DEVELOPMENTS 192
11 COMPANY PROFILES 193
11.1 KEY PLAYERS 193
11.1.1 SEPTODONT HOLDING 193
11.1.1.1 Business overview 193
11.1.1.2 Products/Services/Solutions offered 194
11.1.1.3 Recent developments 195
11.1.1.3.1 Product launches 195
11.1.1.3.2 Deals 195
11.1.1.3.3 Expansions 196
11.1.1.4 MnM view 196
11.1.1.4.1 Right to win 196
11.1.1.4.2 Strategic choices 197
11.1.1.4.3 Weaknesses & competitive threats 197
11.1.2 DENTSPLY SIRONA 198
11.1.2.1 Business overview 198
11.1.2.2 Products/Services/Solutions offered 199
11.1.2.3 Recent developments 200
11.1.2.3.1 Deals 200
11.1.2.4 MnM view 201
11.1.2.4.1 Right to win 201
11.1.2.4.2 Strategic choices 201
11.1.2.4.3 Weaknesses & competitive threats 201
11.1.3 PIERREL 202
11.1.3.1 Business overview 202
11.1.3.2 Products/Services/Solutions offered 202
11.1.3.3 Recent developments 203
11.1.3.3.1 Product launches 203
11.1.3.3.2 Deals 203
11.1.3.4 MnM view 204
11.1.3.4.1 Right to win 204
11.1.3.4.2 Strategic choices 204
11.1.3.4.3 Weaknesses & competitive threats 204
11.1.4 HUONS GLOBAL 205
11.1.4.1 Business overview 205
11.1.4.2 Products/Services/Solutions offered 206
11.1.4.3 Recent developments 207
11.1.4.3.1 Expansions 207
11.1.4.3.2 Other developments 207
11.1.4.4 MnM view 207
11.1.4.4.1 Right to win 207
11.1.4.4.2 Strategic choices 207
11.1.4.4.3 Weaknesses & competitive threats 208
11.1.5 NORMON 209
11.1.5.1 Business overview 209
11.1.5.2 Products/Services/Solutions offered 209
11.1.5.3 MnM view 210
11.1.5.3.1 Right to win 210
11.1.5.3.2 Strategic choices 210
11.1.5.3.3 Weaknesses & competitive threats 211
?
11.1.6 DFL IND?STRIA E COM?RCIO S/A 212
11.1.6.1 Business overview 212
11.1.6.2 Products/Services/Solutions offered 212
11.1.7 ULTRADENT PRODUCTS INC. 213
11.1.7.1 Business overview 213
11.1.7.2 Products/Services/Solutions offered 213
11.1.7.3 Recent developments 214
11.1.7.3.1 Deals 214
11.1.7.3.2 Expansions 214
11.1.7.3.3 Other developments 214
11.1.8 PRIMEX PHARMACEUTICALS 215
11.1.8.1 Business overview 215
11.1.8.2 Products/Services/Solutions offered 215
11.1.9 KEYSTONE INDUSTRIES 216
11.1.9.1 Business overview 216
11.1.9.2 Products/Services/Solutions offered 216
11.1.10 CLARBEN LABORATORIES 217
11.1.10.1 Business overview 217
11.1.10.2 Products/Services/Solutions offered 218
11.1.11 HIKMA PHARMACEUTICALS PLC 219
11.1.11.1 Business overview 219
11.1.11.2 Products/Services/Solutions offered 220
11.1.12 ZEYCO 221
11.1.12.1 Business overview 221
11.1.12.2 Products/Services/Solutions offered 222
11.1.13 NEW STETIC S.A. 223
11.1.13.1 Business overview 223
11.1.13.2 Products/Services/Solutions offered 224
11.1.14 CETYLITE, INC. 225
11.1.14.1 Business overview 225
11.1.14.2 Products/Services/Solutions offered 225
11.1.15 ICPA HEALTH PRODUCTS LIMITED 226
11.1.15.1 Business overview 226
11.1.15.2 Products/Services/Solutions offered 226
11.2 OTHER PLAYERS 227
11.2.1 CENTRIX, INC. 227
11.2.2 ZYMETH PHARMACEUTICAL 228
11.2.3 DMG AMERICA LLC 229
11.2.4 GC SHOWAYAKUHIN CORPORATION 230
11.2.5 YOUNG INNOVATIONS, INC. 231
11.2.6 CROSSTEX INTERNATIONAL, INC. 232
11.2.7 MARK3 (CARGUS INTERNATIONAL, INC.) 233
11.2.8 J. MORITA CORP. 234
11.2.9 KULZER GMBH 235
11.2.10 INTEGRA LIFESCIENCES CORPORATION 236
12 APPENDIX 237
12.1 DISCUSSION GUIDE 237
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 241
12.3 CUSTOMIZATION OPTIONS 243
12.4 RELATED REPORTS 243
12.5 AUTHOR DETAILS 244



List of Figures

FIGURE 1 DENTAL ANESTHETICS MARKET SEGMENTATION & REGIONAL SCOPE 24
FIGURE 2 RESEARCH DESIGN 27
FIGURE 3 PRIMARY SOURCES 30
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 32
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 33
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: SEPTODONT HOLDING 35
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL ANESTHETICS MARKET (2024) 36
FIGURE 10 BOTTOM-UP APPROACH 36
FIGURE 11 TOP-DOWN APPROACH 37
FIGURE 12 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (2025–2030) 38
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 14 DATA TRIANGULATION METHODOLOGY 40
FIGURE 15 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2025 VS. 2030 (USD MILLION) 43
FIGURE 16 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2025 VS. 2030 (USD MILLION) 44
FIGURE 17 DENTAL ANESTHETICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44
FIGURE 18 GEOGRAPHIC SNAPSHOT OF DENTAL ANESTHETICS MARKET 45
FIGURE 19 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 46
FIGURE 20 INJECTABLE ANESTHETICS SEGMENT IN SOUTH KOREA LED ASIA PACIFIC
MARKET IN 2024 47
FIGURE 21 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48
FIGURE 22 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 48
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49
FIGURE 24 DENTAL ANESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 51
FIGURE 25 UK: PROJECTED NUMBER OF ADULTS (16?YEARS AND OLDER) WITH DENTAL CARIES, 2020–2050 (MILLION) 52
FIGURE 26 DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL ANESTHETICS MARKET (JANUARY 2014–DECEMBER 2024) 74
FIGURE 28 TOP PATENT APPLICANT COUNTRIES FOR DENTAL ANESTHETICS
(JANUARY 2014–DECEMBER 2024) 75
FIGURE 29 DENTAL ANESTHETICS MARKET: VALUE CHAIN ANALYSIS 77
FIGURE 30 DENTAL ANESTHETICS MARKET: ECOSYSTEM ANALYSIS 78
FIGURE 31 DENTAL ANESTHETICS MARKET: SUPPLY CHAIN ANALYSIS 79
FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN DENTAL ANESTHETICS MARKET 82
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 82
FIGURE 34 KEY BUYING CRITERIA FOR END USERS 83
FIGURE 35 DENTAL ANESTHETICS MARKET: ADJACENT MARKET ANALYSIS 84
FIGURE 36 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 122
FIGURE 37 EUROPE: DENTAL ANESTHETICS MARKET SNAPSHOT 125
FIGURE 38 NORTH AMERICA: DENTAL ANESTHETICS MARKET SNAPSHOT 141
FIGURE 39 ASIA PACIFIC: DENTAL ANESTHETICS MARKET SNAPSHOT 148
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL ANESTHETICS
MARKET (2024) 178
FIGURE 41 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 181
FIGURE 42 DENTAL ANESTHETICS MARKET: COMPANY FOOTPRINT 182
FIGURE 43 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 187
FIGURE 44 EV/EBITDA OF KEY VENDORS 189
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 189
FIGURE 46 DENTAL ANESTHETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 190
FIGURE 47 DENTSPLY SIRONA: COMPANY SNAPSHOT 199
FIGURE 48 HUONS GLOBAL: COMPANY SNAPSHOT 206
FIGURE 49 HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT 220

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES 26
TABLE 2 DENTAL ANESTHETICS MARKET: RISK ASSESSMENT ANALYSIS 42
TABLE 3 PROJECTED INCREASE IN NUMBER OF PEOPLE AGED OVER 65 YEARS BY REGION, 2019 VS. 2050 (MILLION) 53
TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY SERVICES 2021 VS. 2022 55
TABLE 5 US: RECENT DEALS BACKED BY PRIVATE EQUITY, 2020–2024 56
TABLE 6 AVERAGE PROCEDURAL COST IN TOP TEN DENTAL TOURISM DESTINATIONS (USD) 59
TABLE 7 DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 65
TABLE 13 DENTAL ANESTHETICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 69
TABLE 14 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION, 2023–2025 (USD) 70
TABLE 15 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER, 2024 70
TABLE 16 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390) BY COUNTRY, 2020–2024 (USD THOUSAND) 72
TABLE 17 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390) BY COUNTRY, 2020–2024 (USD THOUSAND) 72
TABLE 18 LIST OF PATENTS IN DENTAL ANESTHETICS MARKET (2022?2024) 75
TABLE 19 DENTAL ANESTHETICS MARKET: ROLE IN ECOSYSTEM 78
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 83
TABLE 21 KEY BUYING CRITERIA FOR END USERS 83
TABLE 22 DENTAL ANESTHETICS MARKET: UNMET NEEDS 84
TABLE 23 DENTAL ANESTHETICS MARKET: END-USER EXPECTATIONS 85
TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 87
TABLE 25 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR DENTAL PRODUCTS 88
TABLE 26 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 90
TABLE 27 DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 28 DENTAL ANESTHETICS MARKET FOR LIDOCAINE, BY COUNTRY 2023–2030 (USD MILLION) 93
TABLE 29 DENTAL ANESTHETICS MARKET FOR MEPIVACAINE, BY COUNTRY 2023–2030 (USD MILLION) 95
TABLE 30 DENTAL ANESTHETICS MARKET FOR ARTICAINE, BY COUNTRY 2023–2030 (USD MILLION) 97
TABLE 31 DENTAL ANESTHETICS MARKET FOR BUPIVACAINE, BY COUNTRY 2023–2030 (USD MILLION) 99
TABLE 32 DENTAL ANESTHETICS MARKET FOR PRILOCAINE, BY COUNTRY 2023–2030 (USD MILLION) 100
TABLE 33 DENTAL ANESTHETICS MARKET FOR OTHER DRUG TYPES, BY COUNTRY 2023–2030 (USD MILLION) 102
TABLE 34 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 104
TABLE 35 DENTAL ANESTHETICS MARKET FOR ROUTE OF ADMINISTRATION BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 36 TOPICAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 37 INJECTABLE ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 38 INJECTABLE ANESTHETICS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 110
TABLE 39 SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 40 NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 41 DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 115
TABLE 42 DENTAL ANESTHETICS MARKET FOR HOSPITALS, BY COUNTRY 2023–2030 (USD MILLION) 116
TABLE 43 DENTAL ANESTHETICS MARKET FOR DENTAL CLINICS, BY COUNTRY 2023–2030 (USD MILLION) 118
TABLE 44 DENTAL ANESTHETICS MARKET FOR OTHER END USERS, BY COUNTRY
2023–2030 (USD MILLION) 120
TABLE 45 DENTAL ANESTHETICS MARKET, BY REGION, 2023–2030 (USD MILLION) 123
TABLE 46 EUROPE: DENTAL ANESTHETICS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 126
TABLE 47 EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 126
TABLE 48 EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 127
TABLE 49 EUROPE: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 127
TABLE 50 GERMANY: DENTIST POPULATION, 2019–2022 128
TABLE 51 GERMANY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 128
TABLE 52 GERMANY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 129
TABLE 53 GERMANY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 129
TABLE 54 GERMANY: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 129
TABLE 55 ITALY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 130
TABLE 56 ITALY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 131
TABLE 57 ITALY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 131
TABLE 58 ITALY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 131
TABLE 59 SPAIN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 132
TABLE 60 SPAIN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 133
TABLE 61 SPAIN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 133
TABLE 62 SPAIN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 133
TABLE 63 FRANCE: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 134
TABLE 64 FRANCE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 135
TABLE 65 FRANCE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 135
TABLE 66 FRANCE: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 135
TABLE 67 UK: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 136
TABLE 68 UK: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 137
TABLE 69 UK: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 137
TABLE 70 UK: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 137
TABLE 71 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 138
TABLE 72 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 139
TABLE 73 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 139
TABLE 74 US: DENTAL EXPENDITURE, 2014–2023 (USD BILLION) 140
TABLE 75 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 141
TABLE 76 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 142
TABLE 77 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 142
TABLE 78 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 142
TABLE 79 US: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 143
TABLE 80 US: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 144
TABLE 81 US: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 144
TABLE 82 CANADA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 145
TABLE 83 CANADA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 145
TABLE 84 CANADA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 146
TABLE 85 CANADA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 146
TABLE 86 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 149
TABLE 87 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 149
TABLE 88 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 150
TABLE 89 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 150
TABLE 90 SOUTH KOREA: FOREIGN PATIENTS VISITING DENTAL FACILITIES 2017–2021 151
TABLE 91 SOUTH KOREA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 151
TABLE 92 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 152
TABLE 93 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 152
TABLE 94 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 152
TABLE 95 JAPAN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 153
TABLE 96 JAPAN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 154
TABLE 97 JAPAN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 154
TABLE 98 JAPAN: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 154
TABLE 99 CHINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 155
TABLE 100 CHINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 156
TABLE 101 CHINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 156
TABLE 102 CHINA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 156
TABLE 103 INDIA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 157
TABLE 104 INDIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 158
TABLE 105 INDIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 158
TABLE 106 INDIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 158
TABLE 107 AUSTRALIA: MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 159
TABLE 108 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 159
TABLE 109 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 160
TABLE 110 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 160
TABLE 111 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 161
TABLE 112 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 161
TABLE 113 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 162
TABLE 114 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY 2023–2030 (USD MILLION) 163
TABLE 115 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 163
TABLE 116 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 164
TABLE 117 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 164
TABLE 118 BRAZIL: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 165
TABLE 119 BRAZIL: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 165
TABLE 120 BRAZIL: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 165
TABLE 121 BRAZIL: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 166
TABLE 122 ARGENTINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 166
TABLE 123 ARGENTINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 167
TABLE 124 ARGENTINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 167
TABLE 125 ARGENTINA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 167
TABLE 126 MEXICO: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 168
TABLE 127 MEXICO: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 169
TABLE 128 MEXICO: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 169
TABLE 129 MEXICO: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 169
TABLE 130 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 170
TABLE 131 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 170
TABLE 132 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 171
TABLE 133 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE 2023–2030 (USD MILLION) 172
TABLE 134 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 172
TABLE 135 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 173
TABLE 136 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–
2030 (USD MILLION) 174
TABLE 137 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 174
TABLE 138 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY END USER 2023–2030 (USD MILLION) 175
TABLE 139 STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL ANESTHETICS MARKET, JANUARY 2021–MARCH 2025 177
TABLE 140 DENTAL ANESTHETICS MARKET: DEGREE OF COMPETITION 179
TABLE 141 DENTAL ANESTHETICS MARKET: REGION FOOTPRINT 183
TABLE 142 DENTAL ANESTHETICS MARKET: DRUG TYPE FOOTPRINT 184
TABLE 143 DENTAL ANESTHETICS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT 185
TABLE 144 DENTAL ANESTHETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 188
TABLE 145 DENTAL ANESTHETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 188
TABLE 146 DENTAL ANESTHETICS MARKET: PRODUCT LAUNCHES JANUARY 2021–MARCH 2025 191
TABLE 147 DENTAL ANESTHETICS MARKET: DEALS, JANUARY 2021–MARCH 2025 191
TABLE 148 DENTAL ANESTHETICS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025 192
TABLE 149 DENTAL ANESTHETICS MARKET: OTHER DEVELOPMENTS JANUARY 2021–MARCH 2025 192
TABLE 150 SEPTODONT HOLDING: COMPANY OVERVIEW 193
TABLE 151 SEPTODONT HOLDING: PRODUCTS/SERVICES/SOLUTIONS OFFERED 194
TABLE 152 SEPTODONT HOLDING: PRODUCTS LAUNCHES, JANUARY 2021–MARCH 2025 195
TABLE 153 SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025 195
TABLE 154 SEPTODONT HOLDING: EXPANSIONS, JANUARY 2021–MARCH 2025 196
TABLE 155 DENTSPLY SIRONA: COMPANY OVERVIEW 198
TABLE 156 DENTSPLY SIRONA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 199
TABLE 157 DENTSPLY SIRONA: DEALS, JANUARY 2021–MARCH 2025 200
TABLE 158 PIERREL: COMPANY OVERVIEW 202
TABLE 159 PIERREL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 202
TABLE 160 PIERREL: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 203
TABLE 161 PIERREL: DEALS, JANUARY 2021–MARCH 2025 203
TABLE 162 HUONS GLOBAL: COMPANY OVERVIEW 205
TABLE 163 HUONS GLOBAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 206
TABLE 164 HUONS GLOBAL: EXPANSIONS, JANUARY 2021–MARCH 2025 207
TABLE 165 HUONS GLOBAL: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 207
TABLE 166 NORMON: COMPANY OVERVIEW 209
TABLE 167 NORMON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 209
TABLE 168 DFL IND?STRIA E COM?RCIO S/A: COMPANY OVERVIEW 212
TABLE 169 DFL IND?STRIA E COM?RCIO S/A: PRODUCTS/SERVICES/SOLUTIONS OFFERED 212
TABLE 170 ULTRADENT PRODUCTS INC.: COMPANY OVERVIEW 213
TABLE 171 ULTRADENT PRODUCTS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 213
TABLE 172 ULTRADENT PRODUCTS INC.: DEALS, JANUARY 2021–MARCH 2025 214
TABLE 173 ULTRADENT PRODUCTS INC.: EXPANSIONS, JANUARY 2021–MARCH 2025 214
TABLE 174 ULTRADENT PRODUCTS INC.: OTHER DEVELOPMENTS JANUARY 2021–MARCH 2025 214
TABLE 175 PRIMEX PHARMACEUTICALS: COMPANY OVERVIEW 215
TABLE 176 PRIMEX PHARMACEUTICALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 215
TABLE 177 KEYSTONE INDUSTRIES: COMPANY OVERVIEW 216
TABLE 178 KEYSTONE INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 216
TABLE 179 CLARBEN LABORATORIES: COMPANY OVERVIEW 217
TABLE 180 CLARBEN LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 218
TABLE 181 HIKMA PHARMACEUTICALS PLC: COMPANY OVERVIEW 219
TABLE 182 HIKMA PHARMACEUTICALS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 220
TABLE 183 ZEYCO: COMPANY OVERVIEW 221
TABLE 184 ZEYCO: PRODUCTS/SERVICES/SOLUTIONS OFFERED 222
TABLE 185 NEW STETIC S.A.: COMPANY OVERVIEW 223
TABLE 186 NEW STETIC S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 224
TABLE 187 CETYLITE, INC.: COMPANY OVERVIEW 225
TABLE 188 CETYLITE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 225
TABLE 189 ICPA HEALTH PRODUCTS LIMITED: COMPANY OVERVIEW 226
TABLE 190 ICPA HEALTH PRODUCTS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226
TABLE 191 CENTRIX, INC.: COMPANY OVERVIEW 227
TABLE 192 ZYMETH PHARMACEUTICAL: COMPANY OVERVIEW 228
TABLE 193 DMG AMERICA LLC: COMPANY OVERVIEW 229
TABLE 194 GC SHOWAYAKUHIN CORPORATION: COMPANY OVERVIEW 230
TABLE 195 YOUNG INNOVATIONS, INC.: COMPANY OVERVIEW 231
TABLE 196 CROSSTEX INTERNATIONAL, INC.: COMPANY OVERVIEW 232
TABLE 197 MARK3 (CARGUS INTERNATIONAL, INC.): COMPANY OVERVIEW 233
TABLE 198 J. MORITA CORP.: COMPANY OVERVIEW 234
TABLE 199 KULZER GMBH: COMPANY OVERVIEW 235
TABLE 200 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 236